Preparative Regimen Dosing for Hematopoietic Stem Cell Transplantation in Patients with Chronic Kidney Disease: Analysis of the Literature and Recommendations
Authors:
Open Access
- 1 July 2014
- journal article
- review article
- Published by Elsevier in Transplantation and Cellular Therapy
- Vol. 20 (7) , 908-919
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Acute kidney injury following HCT: incidence, risk factors and outcomeBone Marrow Transplantation, 2011
- Hematopoietic Stem Cell Transplantation in Patients With Chronic Kidney DiseaseSeminars in Nephrology, 2010
- A Risk Score for Mortality after Allogeneic Hematopoietic Cell TransplantationAnnals of Internal Medicine, 2006
- Acute renal failure in hematopoietic cell transplantationKidney International, 2006
- Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCTBlood, 2005
- Comparison of renal injury in myeloablative autologous, myeloablative allogeneic and non-myeloablative allogeneic haematopoietic cell transplantationNephrology Dialysis Transplantation, 2005
- Administration and pharmacokinetics of high-dose cyclophosphamide with hemodialysis support for allogeneic bone marrow transplantation in acute leukemia and end-stage renal diseaseBone Marrow Transplantation, 1999
- Total body irradiation and cyclophosphamide is a conditioning regimen for unrelated bone marrow transplantation in a patient with chronic myelogenous leukemia and renal failure on hemodialysisBone Marrow Transplantation, 1998
- High-dose chemotherapy and autologous peripheral blood stem cell transplantation in patients with multiple myeloma and renal insufficiencyBone Marrow Transplantation, 1997
- Acute Renal Failure Following Bone Marrow Transplantation: A Retrospective Study of 272 PatientsAmerican Journal of Kidney Diseases, 1989